IOFINA PLC - Audited full-year results for the 12 months to 31 December 2025

Iofina Plc delivered a strong investor update highlighting record financial results, accelerating iodine production growth, and an expanded long-term growth strategy. The specialty chemical company reported 2025 revenue of $66.5 million, up 22% year-on-year, alongside record EBITDA, improved margins, and record crystalline iodine production of 743 metric tonnes driven by higher iodine prices and operational expansion. Management emphasized continued execution of its growth strategy through the successful launch of the IO#11 plant in Oklahoma and the construction of a new large-scale iodine extraction facility in the Permian Basin, expected online in Q3 2026. Iofina expects the new plant to significantly increase production capacity, taking the business close to a 1,000 metric tonne annual run rate, with a medium-term target of 2,000 metric tonnes within 3–4 years. The company highlighted strong cash generation, disciplined capital allocation, a net cash position of $5.2 million, and access to debt facilities to support future expansion. Management also noted robust demand trends in the global iodine market, particularly from healthcare, X-ray contrast media, pharmaceuticals, LCD screens, and industrial applications. With over 10 potential new plant opportunities under evaluation, Iofina believes its proprietary IOsorb® technology, scalable production model, and expanding customer base position the group for sustained revenue growth, increasing profitability, and long-term shareholder value creation.